Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Deblon, Nicolas ^a   Veyrat Durebex, Christelle ^a   Bourgoin, Lucie ^a   Caillon, Aurélie ^a   Bussier, Anne Lise ^a   Petrosino, Stefania ^b   Piscitelli, Fabiana ^b   Legros, Jean Jacques ^c   Geenen, Vincent ^c   Foti, Michelangelo ^a   Wahli, Walter ^d   Di Marzo, Vincenzo ^b   Rohner Jeanrenaud, Françoise ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b CNR   (Italy)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; N OLEOYLETHANOLAMINE; OXYTOCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; ANTIOBESITY AGENT; OLEIC ACID;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; FATTY ACID OXIDATION; GENE EXPRESSION; GLUCOSE INTOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOLYSIS; MALE; NONHUMAN; OBESITY; RAT; TISSUE METABOLISM; TREATMENT RESPONSE; WEIGHT REDUCTION; ANIMAL; BIOSYNTHESIS; BLOOD; DIET; DOSE RESPONSE; DRUG EFFECT; GENE INACTIVATION; GENETICS; METABOLISM; MOUSE; PATHOPHYSIOLOGY;

ANIMALIA; MUS; RATTUS;

ADIPOSE TISSUE; ANIMALS; ANTI-OBESITY AGENTS; BODY WEIGHT; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE KNOCKOUT TECHNIQUES; INSULIN RESISTANCE; MALE; MICE; OBESITY; OLEIC ACIDS; OXYTOCIN; PPAR ALPHA; RATS;

EID: 80053201741     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025565     Document Type: Article

References (42)

1. Gimpl G, Fahrenholz F, (2001) The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81: 629-683.
2. Arletti R, Benelli A, Bertolini A, (1989) Influence of oxytocin on feeding behavior in the rat. Peptides 10: 89-93.
3. Swaab DF, Purba JS, Hofman MA, (1995) Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J Clin Endocrinol Metab 80: 573-579.
4. Camerino C, (2009) Low sympathetic tone and obese phenotype in oxytocin-deficient mice. Obesity (Silver Spring) 17: 980-984.
5. Takayanagi Y, Kasahara Y, Onaka T, Takahashi N, Kawada T, et al. (2008) Oxytocin receptor-deficient mice developed late-onset obesity. Neuroreport 19: 951-955.
6. Zhang G, Bai H, Zhang H, Dean C, Wu Q, et al. (2011) Neuropeptide exocytosis involving synaptotagmin-4 and oxytocin in hypothalamic programming of body weight and energy balance. Neuron 69: 523-535.
7. Lo Verme J, Gaetani S, Fu J, Oveisi F, Burton K, et al. (2005) Regulation of food intake by oleoylethanolamide. Cell Mol Life Sci 62: 708-716.
8. Elabd C, Basillais A, Beaupied H, Breuil V, Wagner N, et al. (2008) Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis. Stem Cells 26: 2399-2407.
9. Muchmore DB, Little SA, de Haen C, (1981) A dual mechanism of action of ocytocin in rat epididymal fat cells. J Biol Chem 256: 365-372.
10. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, et al. (1995) Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15: 3012-3022.
11. Rohner-Jeanrenaud F, Walker CD, Greco-Perotto R, Jeanrenaud B, (1989) Central corticotropin-releasing factor administration prevents the excessive body weight gain of genetically obese (fa/fa) rats. Endocrinology 124: 733-739.
12. Pequeux C, Hendrick JC, Hagelstein MT, Geenen V, Legros JJ, (2001) Novel plasma extraction procedure and development of a specific enzyme-immunoassay of oxytocin: application to clinical and biological investigations of small cell carcinoma of the lung. Scand J Clin Lab Invest 61: 407-415.
13. Vettor R, Zarjevski N, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B, (1994) Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia 37: 1202-1208.
14. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, et al. (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530-534.
15. Foti M, Porcheron G, Fournier M, Maeder C, Carpentier JL, (2007) The neck of caveolae is a distinct plasma membrane subdomain that concentrates insulin receptors in 3T3-L1 adipocytes. Proc Natl Acad Sci U S A 104: 1242-1247.
16. Olson AL, Knight JB, Pessin JE, (1997) Syntaxin 4, VAMP2, and/or VAMP3/cellubrevin are functional target membrane and vesicle SNAP receptors for insulin-stimulated GLUT4 translocation in adipocytes. Mol Cell Biol 17: 2425-2435.
17. Gould BR, Zingg HH, (2003) Mapping oxytocin receptor gene expression in the mouse brain and mammary gland using an oxytocin receptor-LacZ reporter mouse. Neuroscience 122: 155-167.
18. Tsuda T, Ueno Y, Yoshikawa T, Kojo H, Osawa T, (2006) Microarray profiling of gene expression in human adipocytes in response to anthocyanins. Biochem Pharmacol 71: 1184-1197.
19. Schaffler A, Binart N, Scholmerich J, Buchler C, (2005) Hypothesis paper Brain talks with fat-evidence for a hypothalamic-pituitary-adipose axis? Neuropeptides 39: 363-367.
20. Kusui C, Kimura T, Ogita K, Nakamura H, Matsumura Y, et al. (2001) DNA methylation of the human oxytocin receptor gene promoter regulates tissue-specific gene suppression. Biochem Biophys Res Commun 289: 681-686.
21. Popeijus HE, Saris WH, Mensink RP, (2008) Role of stearoyl-CoA desaturases in obesity and the metabolic syndrome. Int J Obes (Lond) 32: 1076-1082.
22. Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, et al. (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425: 90-93.
23. Guzman M, Lo Verme J, Fu J, Oveisi F, Blazquez C, et al. (2004) Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). J Biol Chem 279: 27849-27854.
24. Fu J, Oveisi F, Gaetani S, Lin E, Piomelli D, (2005) Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats. Neuropharmacology 48: 1147-1153.
25. Miyazaki M, Ntambi JM, (2003) Role of stearoyl-coenzyme A desaturase in lipid metabolism. Prostaglandins Leukot Essent Fatty Acids 68: 113-121.
26. Brown JM, Rudel LL, (2010) Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery. Curr Opin Lipidol 21: 192-197.
27. Ariyama H, Kono N, Matsuda S, Inoue T, Arai H, (2010) Decrease in membrane phospholipid unsaturation induces unfolded protein response. J Biol Chem.
28. Miyazaki M, Man WC, Ntambi JM, (2001) Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid. J Nutr 131: 2260-2268.
29. Collins JM, Neville MJ, Hoppa MB, Frayn KN, (2010) De novo lipogenesis and stearoyl-CoA desaturase are coordinately regulated in the human adipocyte and protect against palmitate-induced cell injury. J Biol Chem 285: 6044-6052.
30. Bjorkstrand E, Eriksson M, Uvnas-Moberg K, (1992) Plasma levels of oxytocin after food deprivation and hypoglycaemia, and effects of 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin on blood glucose in rats. Acta Physiol Scand 144: 355-359.
31. Izzo AA, Piscitelli F, Capasso R, Marini P, Cristino L, et al. (2010) Basal and fasting/refeeding-regulated tissue levels of endogenous PPAR-alpha ligands in Zucker rats. Obesity (Silver Spring) 18: 55-62.
32. Jeong S, Yoon M, (2009) Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARalpha in high fat diet-induced obese mice. Exp Mol Med 41: 397-405.
33. Dobrzyn P, Sampath H, Dobrzyn A, Miyazaki M, Ntambi JM, (2008) Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart. Am J Physiol Endocrinol Metab 294: E357-364.
34. Dobrzyn P, Pyrkowska A, Jazurek M, Szymanski K, Langfort J, et al. (2010) Endurance training-induced accumulation of muscle triglycerides is coupled to upregulation of stearoyl-CoA desaturase 1. J Appl Physiol.
35. Gaetani S, Fu J, Cassano T, Dipasquale P, Romano A, et al. (2010) The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin. J Neurosci 30: 8096-8101.
36. Gonzalez-Yanes C, Serrano A, Bermudez-Silva FJ, Hernandez-Dominguez M, Paez-Ochoa MA, et al. (2005) Oleylethanolamide impairs glucose tolerance and inhibits insulin-stimulated glucose uptake in rat adipocytes through p38 and JNK MAPK pathways. Am J Physiol Endocrinol Metab 289: E923-929.
37. Brunton PJ, Russell JA, (2008) The expectant brain: adapting for motherhood. Nat Rev Neurosci 9: 11-25.
38. Yogev Y, Visser GH, (2009) Obesity, gestational diabetes and pregnancy outcome. Semin Fetal Neonatal Med 14: 77-84.
39. Jensen DR, Gavigan S, Sawicki V, Witsell DL, Eckel RH, et al. (1994) Regulation of lipoprotein lipase activity and mRNA in the mammary gland of the lactating mouse. Biochem J 298 (Pt 2): 321-327.
40. Takagi T, Tanizawa O, Otsuki Y, Sugita N, Haruta M, et al. (1985) Oxytocin in the cerebrospinal fluid and plasma of pregnant and nonpregnant subjects. Horm Metab Res 17: 308-310.
41. Fuchs AR, Fuchs F, Husslein P, Soloff MS, Fernstrom MJ, (1982) Oxytocin receptors and human parturition: a dual role for oxytocin in the initiation of labor. Science 215: 1396-1398.
42. Murata T, Murata E, Liu CX, Narita K, Honda K, et al. (2000) Oxytocin receptor gene expression in rat uterus: regulation by ovarian steroids. J Endocrinol 166: 45-52.